Benitec Biopharma Inc. (BNTC) Financials
BNTC Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 21.4 million | 5.9 million |
2023-09-30 | 27.1 million | 4.7 million |
2023-06-30 | 4.5 million | 4.3 million |
2023-03-31 | 8.2 million | 3.5 million |
BNTC Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -5.4 million | 93000 |
2023-09-30 | -4.6 million | 91000 |
2023-06-30 | -4.1 million | 127000 |
2023-03-31 | -4.0 million | 71000 |
BNTC Net Income
No data available :(
BNTC Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 20.4 million | - | 423000 |
2023-09-30 | 25.9 million | - | 491000 |
2023-06-30 | 2.5 million | - | 559000 |
2023-03-31 | 6.6 million | - | 623000 |
BNTC Shares Outstanding
BNTC Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | 5.1 million | 1.8 million | - |
2023-09-30 | - | 4.4 million | 1.6 million | - |
2023-06-30 | 1000 | 3.2 million | 1.4 million | - |
2023-03-31 | 1000 | 3.2 million | 1.2 million | - |
BNTC Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | 1000 |
2023-09-30 | - | -106000 |
2023-06-30 | 7000 | 84000 |
2023-03-31 | 54000 | 32000 |
BNTC
Price: $8.64
52 week price:
Earnings Per Share: -236.13 USD
P/E Ratio: -0.01
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 208500
Ebitda: -11.8 millionMarket Capitalization: 14.4 million